NT
Therapeutic Areas
Ambrosia Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GLP1R Agonist | Obesity/Metabolic Disorders | Preclinical |
| GIPR Antagonist | Obesity/Metabolic Disorders | Discovery |
| Amylin Agonist | Obesity/Metabolic Disorders | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| GLP1R Agonist | Obesity/Metabolic Disorders | Preclinical |
| GIPR Antagonist | Obesity/Metabolic Disorders | Discovery |
| Amylin Agonist | Obesity/Metabolic Disorders | Discovery |